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Mutagenicity of the Halogenated Olefin,
2-Bromo-2-chloro-1,1-difluoroethylene,
A Presumed Metabolite of the
Inhalation Anesthetic Halothane
by A. J. Garro* and R. A. Phillips*
The presumed halothane metabolite, 2-bromo-2-chloro-1, 1-difluoroethylene, produces both base sub-
stitution andframeshiftmutations in Salmonella typhimurium. Directmutagenesis ofisolated DNAalso
was observed by using a Bacillus subtilis transformation assay to score the production of mutagenic
lesions in transforming DNA.
Introduction
The discovery that the halogenated olefin, vinyl
chloride, is carcinogenic (1-3) prompted investiga-
tions into the biological activities of this and other
structurally related compounds. As a result ofthese
studies two additional halogenated olefins, vinyl-
idene chloride, which like vinyl chloride is used in
large volumes in the synthesis of plastics, and tri-
chloroethylene, used primarily as an industrial de-
greasing agent, have recently been identified as car-
cinogens and mutagens (4-7).
Halothane (2-bromo-2-chloro- 1,1,1-trifluoroethane)
is a commonly used inhalation anesthetic. As much
as 25% of the halothane absorbed during the course
of anesthesia is metabolized (8) and the metabolic
scheme shown in Fig. 1 was recently suggested by
Cohen et al. (9) to explain the formation ofthe three
major urinary metabolites identified in man. The
proposed dehydrofluorination intermediate,
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tWe recently were informed by Dr. V. Simmons of the Stan-
ford Research Institute, that the preparation ofBCD used in this
study was only about 63% pure. Approximately 30% ofthe prep-
aration consisted of CF2CH2Cl, one of the intermediates in the
chemical synthesis of BCD, and approximately 5% consisted of
a mixture of unidentified compounds. All of these compounds
co-chromatographed on the column used by the manufacturer.
This finding raises serious questions regarding which of the
above compounds is responsible for the mutagenic activity we
observed.
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2-bromo-2-chloro-1,1-difluoroethylene (BCD), is of
particular interest because of its structural similar-
ity to the carcinogenic haloalkenes. In this regard
there has been a growing concern, based on
epidemiological studies (10, 11), that chronic, low-
dose exposure, among anesthesia personnel, to in-
halation anesthetics may be associated with an in-
creased incidence of cancer, spontaneous miscar-
riages and births involving congenital anomalies.
In this communication we report the results of
experiments in which BCD was tested for its capac-
ity to induce mutations in two independent assays.
The first of these, the Ames Salmonella auxotroph
reversion test, utilizes a set of S. typhimliriiim
strains which have been modified specifically for
use in mutagen screening (12). Of the known car-
cinogens which have been tested in this system,
85% are detectable as mutagens while the incidence
of false-positives is less than 10% (4). The second
assay utilizes a transformable strain ofBacillus suib-
tilis to score the formation of mutagenic lesions
produced by interaction oftest compounds with iso-
lated transforming DNA. In this assay it is possible
to determine whether the test compound is capable
of direct reaction with DNA independent of any
cellular metabolism.
Materials and Methods
BCD was obtained from the Columbia Organic
Chemicals Co., Columbia, S. C. It was estimated
by the manufacturer, PCR Inc., Gainesville, Fla.,
to be 98.2% pure by gas chromatographic analysis.t
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FIGURE 1. Proposed pathways of halothane metabolism according to Cohen et al. (9). The metabolic intermediates shown were
suggested on the basis of the identified urinary metabolites: trifluoroacetic acid; N-trifluoroacetyl-2-aminoethanol, and N-acetyl-
S-(2-bromo-2-chloro-1, I-difluoroethyl)-L-cysteine.
The principal contaminant is thought to be bromo-
difluor-oacetylchloride which can form by spon-
taneous oxidation and rearrangement of BCD. The
suggestion that bromodifluoroacetylchloride is the
principal contaminant is supported by infrared
spectral analysis which shows the presence of a
ti-ace amount of a carbonyl compound in the BCD
preparation.
The Siallmonella tester strains used in the
mutagenesis assays require histidine for growth and
are reverted to histidine-independence either by
base-substitution mutagens (strains TA92, TAI00
and TA1535) or by frameshift mutagens (strains
TA98, TA1537 and TA1538). Strains TAIO0 and
TA98 are derivatives ofTA 1535 and TA 1538 which
carry an R factor that interferes with accurate re-
pair of damaged DNA and enhances the sensitivity
of these strains to the mutagenic effects of some
carcinogens (12). TA92 carries this same R factor
but differs from TA 100 and TA1535 in having a wild
type cell envelope and is thus less permeable to
some mutagens than TAI00 and TA 1535; it is also
wild type for excision repair of DNA damage which
is defective in TA 100 and TA 1535. BCD was tested
for mutagenic activity on aliquots of the bacteria
growing exponentially in tryptone broth, buffered
to pH 7.4 with 0.O5M sodium phosphate. The BCD
was diluted in ethyl ether and the BCD-bacterial
suspensions were incubated in screw-capped glass
vials at 26°C for 30 min. The numbers of histidine-
independent (His+) revertants in the reaction mix-
tures were determined by streaking samples on min-
imal plates lacking histidine. Total surviving cells
were determined by plating on Difco tryptose blood
agar base medium.
Direct mutagenic activity of BCD on isolated
DNA was assayed by scoring for the induction of
asporagenous (Spo-) mutants in cultures of B. suib-
tilis which had been transformed with BCD-treated
DNA. The DNA used was isolated by the Marmur
method (13) fi-om a Spo+, rifampin-resistant (Rif')
strain of B. subtilis. The genetic locus for Rifr is
tightly linked to a cluster of genes, mutations in
many of which lead to a Spo- phenotype (14). The
isolated DNA was alkali denatured and treated at a
final concentration of 74 ,ug/ml, with BCD in the
presence of 7.2M dimethylformamide, 0. 14M
phosphate pH 7 at 53°C. The dimethylformamide
and elevated temperature were used to minimize
intrastrand base pairing thereby exposing the bases
for reaction with the potential mutagen. The reac-
tion mixture was incubated in a screw-capped glass
tube and then dialyzed against 1000 volumes of
0.15M NaCl, 0.OOSM sodium phosphate, pH 7.2.
The Spo+ Rif` recipient cells were grown to compe-
tence (15) concentrated 10 fold and stored frozen in
10 per cent glycerol at -70°C until use. The cells
were exposed to BCD-treated and control DNA
under conditions optimized for transformation with
single-stranded DNA (16) and then were plated on
sporulation medium (17) containing 10 ,ug/ml rifam-
pin which selects for Rif' transformants. Colonies
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differentiated from those of Spo+ cells since the
former are colorless after 96 hr incubation on this
medium, whereas the Spo+ colonies accumulate a
dark brown pigment. Since the loci specifying Rifr
and Spo- are tightly linked and may be carried on a
single piece of transforming DNA, selection for
Rifr enhances the possibility of detecting cells
which have incorporated a DNA fragment that re-
ceived a mutagenic hit in a sporulation-specific
gene.
This assay is analogous to another described by
Freese and Strack (18) which utilized markers in the
tryptophan (Trp) biosynthetic pathway for detect-
ing DNA-reactive mutagens. The advantage of
scoring for mutants in the sporulation rather than
the tryptophan pathway is the relative sensitivity
with which the Spo- mutants can be detected. A
single Spo- clone is observable against a back-
ground of up to 1000 Spo+ colonies whereas it is
difficult to detect the Trp- mutants, which excrete a
metabolite that fluoresces under ultraviolet light, if
the background ofTrp+ colonies exceeds 100 to 200
per plate.
Results and Discussion
BCD induced both base substitution and
frameshift mutations reverting Salmonella strains
TA92, TA98, and TA100 (Fig. 2). Since all ofthese
are R factor carrying strains the induction of both
types of mutations may be a consequence of error
prone repair of BCD-damaged DNA. The presence
of the wild type cell envelope decreased sensitivity
to BCD mediated mutagenesis. BCD at the con-
centrations used in the above experiments did not
kill the cells. Toxicity as well as an increased
mutagenic effect was observed at higher concentra-
tions (Fig. 3). From its structure BCD is expected
to be highly lipophilic. The concomitant increase in
both toxicity and mutagenesis may reflect BCD
mediated damage to cellular membranes resulting in
an increase in permeability to the mutagen. The in-
creased mutation frequency, i.e., the number of re-
vertants per viable cell observed at the higher BCD
concentrations is not due simply to plating lower
numbers of viable cells on the selective plates.
While it is known that the numbers of revertants
which arise spontaneously during colony formation
are approximately constant over a plating range of
104 to 108 cells, it is possible to correct for these
spontaneous "plate" mutants when calculating the
induced reversion frequency by subtracting the
numbers of His+ revertants observed in the un-
treated samples (19).
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FIGURE 2. BCD induced reversion ofS. typhimurium strains: (A)
TA92; (0) TA98; (.) TA100; (a) TA1535; (A) TA1537; (o)
TA1538. The numbers ofinduced revertants (19) were calcu-
lated as
[(His+ revertants/BCD treated sample)-(His+ revertants/un-
treated sample)])/(survivors/treated sample).
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FIGURE 3. BCD mediated mutagenicity and toxicity on S.
typhimurium strains: (A) TA92; (m) TA98; (A) TA100; (-)
Revertant colony forming units (CFU), (--) Viable cells.
December 1977 67Table 1. BCD-mediated mutagenesis and inactivation of transforming activity of B. subtils DNA.a
Incubation time. BCD added, mmoles Rift transformants/ml Spo-/Rifr colonies
min x 102 X lo-3 X 104
0 0 104 5
15 4.8 26 33
30 9.6 8 112
45 14.4 1 344
60 19.2 1 1,005
aThe DNA was reacted with BCD as described under Methods. The initial reaction volume was 3.6 ml. At each time
point a 0.5 ml sample was removed and 0.05 ml of a 0.96M solution of BCD in ethyl ether was added. The DNA was
dialyzed and added at a final concentration of5.5 ,ug/ml to competent cultures ofB. siubtilis RifK Spo+. The transformation
mixture was incubated at 37°C for 1 hr then diluted 5-fold into nutrient broth and incubation continued for 3 hr prior to
plating to allow expression of the Rifr phenotype.
Increased numbers of Spo- mutants were ob-
served among the cells transformed to Rif with
BCD-treated DNA (Table 1). Inactivation oftrans-
forming activity also was observed and further
studies will be required to determine if mutagenesis
and inactivation are due to the same type of lesion
in the DNA. Distinct mutagenic and inactivating
effects have been observed in a similar assay with
the mutagenic hydroxylamines (20).
Microsomal activation was not required for
mutagenesis either with Salmonella or isolated
DNA. Thus BCD differs from most of the other
mutagenic olefins studied which require metabolism,
presumably to their respective oxiranes for activity
(6, 21). Vinyl chloride also has been shown to be
directly mutagenic for Salmonella (22-24), but this
compound has not been tested for direct
mutagenesis on isolated DNA. The direct
mutagenic effect of vinyl chloride on Salmonella
may be due to free radical formation (24). The
mutagenic effect of BCD may result from direct
reaction with nucleophilic sites on DNA bases.
From the urinary metabolites of halothane which
have been identified it appears that BCD can react
directly with nucleophiles such as glutathione (9).
As noted under Methods, we have been informed
that BCD may spontaneously oxidize to form an
acylhalide. This oxidation product may contribute
to the observed mutagenesis ifpresent or formed in
high enough concentrations during the mutagenesis
assays. It is not known if this oxidation product is
formed in significant amounts in viio but there are
several minor urinary metabolites of halothane
which have not been identified (9). There are also
indications from in vitro studies that there is more
than one halothane metabolite which is capable of
binding to macromolecules (25).
The biological significance of BCD mutagenicity
with respect to the specific morbidities noted in the
epidemiological surveys of anesthesia personnel is
not known. As yet neither ourselves nor others
have been able to observe halothane mediated
mutagenicity even in assays which included an in
iitro metabolic activation system (26). It has re-
cently been reported that the dehydrofluorination of
halothane which would give rise to BCD occurs
only under low 02 tension (25). Thus prior failures
to observe halothane mediated mutagenesis may
have been related to inappropriate in vitro
metabolic activation conditions. In this regard the
present study should be of use in determining the
minimal levels of halothane-derived BCD which
can be detected in standard mutagenesis assays.
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